Outcome after intracranial hemorrhage under dabigatran and reversal with idarucizumab versus under vitamin-K-antagonists – the RIC-ICH study

Overview of attention for article published in Frontiers in Neurology, July 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 10,505 followers.

RT @FrontNeurol: New Research: Outcome after intracranial hemorrhage under dabigatran and reversal with idarucizumab versus under vitamin-K…

24 Jul 2023

Reply Repost Favourite

New Research: Outcome after intracranial hemorrhage under dabigatran and reversal with idarucizumab versus under vitamin-K-antagonists – the RIC-ICH study: Background Intracranial hemorrhage (ICH) is a rare but serious side effect associated… #Neurology h

24 Jul 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.